ctrl K

Watchlist Price Alert

Olema Pharmaceuticals Inc... (OLMA)

NASDAQ: OLMA · Real-Time Price · USD

4.41

-0.09 (-2.00%)

At close: May 15, 2025, 10:46 AM

Olema Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	377K	1.66M	1.66M	11K	9.03K	8.24K
Gross Profit	n/a	-377K	-1.66M	-1.66M	-11K	-9.03K	-8.24K
Operating Income	-142.26M	-104.96M	-106.99M	-71.49M	-21.53M	-4.32M	-2.08M
Interest Income	12.68M	8.32M	2.23M	442K	60K	7K	4K
Pretax Income	-129.47M	-96.66M	-104.79M	-71.1M	-22.12M	-4.32M	-2.2M
Net Income	-129.47M	-96.66M	-102.59M	-70.89M	-22.76M	-4.32M	-2.2M
Selling & General & Admin	17.74M	18.82M	24.71M	20.39M	7.82M	403K	386K
Research & Development	124.52M	86.14M	82.27M	51.1M	13.7M	3.92M	1.69M
Other Expenses	n/a	n/a	-27K	-47K	n/a	n/a	-31K
Operating Expenses	142.26M	104.96M	106.99M	71.49M	21.53M	4.32M	2.08M
Interest Expense	n/a	n/a	n/a	n/a	653K	n/a	28K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	104.96M	106.99M	71.49M	21.53M	4.32M	2.08M
Income Tax Expense	n/a	n/a	-2.2M	-210K	642K	-155.86K	-90K
Shares Outstanding (Basic)	58.74M	45.25M	40M	39.52M	39.31M	40.17M	14.1M
Shares Outstanding (Diluted)	58.74M	45.25M	40M	39.52M	39.31M	40.17M	14.1M
EPS (Basic)	-2.2	-2.14	-2.56	-1.79	-0.58	-0.11	-0.16
EPS (Diluted)	-2.2	-2.14	-2.56	-1.79	-0.58	-0.11	-0.16
EBITDA	-129.08M	-104.58M	-103.13M	-69.43M	-21.52M	-4.31M	-2.16M
EBIT	-129.47M	-104.96M	-106.99M	-71.1M	-21.47M	-4.32M	-2.08M
Depreciation & Amortization	393K	377K	1.66M	1.66M	11K	9.03K	8.24K